Back to Agenda
Session 6: Future Developments and Projects on Clinical Trial Regulations
Session Chair(s)
Nick Sykes, MS
Policy Advisor, Regulatory Strategy, EFPIA, Belgium
The conduct and management of clinical trials continues to evolve. A number of initiatives and programmes have been established to ensure the regulatory oversight of clinical trials is aligned with the way clinical trials are being conducted and planned. This session will explore some of the ongoing work from some of the initiatives and will discuss how they will help ensure clinical research can continue to be conducted effectively and efficiently.
Speaker(s)
Solange Corriol-Rohou, DrMed, MD, PHD
, SCR Consulting, France
Developments in ICH
Magda Chlebus, MA
Executive Director, Science Policy & Regulatory Affairs, EFPIA - European Federation of Pharmaceutical Industries and Associations, Belgium
What has been done in IMI Project (to support Clinical Development)
Alison Bond, PHD
Director, Global Regulatory and R&D Policy, Amgen, United Kingdom
TransCelerate Initiatives to Modernise Clinical Development
Have an account?